Jay Barth

Jay Barth

Company: Lexeo Therapeutics

Job title: Chief Medical Officer

Seminars:

Q&A Panel Discussion 2:30 pm

Read more

day: Day Two

AAV Gene therapy targeting APOE4-associated Alzheimer’s Disease 1:50 pm

Discussing the basis for a gene therapy approach in an Alzheimer’s Disease population Considerations for Phase 1 study design and use of biomarkers Status of clinical trial in APOE4 homozygotes with Alzheimer’s DiseaseRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.